5th Annual Hematologic Malignancies Symposium

Needs Statement

This symposium will bring together recognized national and international speakers to address recent advances in diagnosis of myelodysplastic syndrome (MDS) and measurable residual disease [MRD] directed acute myelogenous leukemia (AML) therapy. During our symposium, we will emphasize the need for physicians to combine up-to-date knowledge and technology to efficiently identify “actionable targets” for treatment of AML and MDS patients. Additionally, we expect to gain insight into promising scientific data that would inform therapy efficacy based on AML MRD evaluation. The symposium will provide important novel development in MDS and AML pathogenesis leading to unique opportunity for clinical trial design ideas.

Educational Objectives

At the conclusion of the conference, participants should be able to:

• Summarize current principles that explain clonal hematopoiesis and acute myelogenous leukemia (AML).
• Describe the current role of targeted clonal hematopoiesis and AML genome.
• Integrate complex clonal hematopoiesis and AML into genomic and therapeutic algorithms.
• Discuss the role of targeted agents in the treatment of clonal hematopoiesis and AML in genomic and therapeutic algorithms.

Target Audience

Accreditation/Credit Designation

PHYSICIAN

Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baylor College of Medicine designates this live activity for a maximum of 4.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC CREDIT

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 4.50 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participant will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

NURSE

Cizik School of Nursing at UTHealth is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. This activity provides 4.50 contact hours of nursing continuing education (CNE). 

Disclosure Policy

Baylor College of Medicine (BCM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. BCM is committed to sponsoring CE activities that are scientifically based, accurate, current, and objectively presented.

In accordance with the ACCME Standards for Commercial Support, BCM has implemented a mechanism requiring everyone in a position to control the content of an educational activity (i.e., directors, planning committee members, faculty) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships at the time of the activity or within 24 months prior.

In addition, BCM has requested activity faculty/presenters to disclose to participants any unlabeled use or investigational use of pharmaceutical/device products; to use scientific or generic names (not trade names) in referring to products; and, if necessary to use a trade name, to use the names of similar products or those within a class. Faculty/presenters have also been requested to adhere to the ACCME's validation of clinical content statements.

BCM does not view the existence of financial relationships with commercial interests as implying bias or decreasing the value of a presentation. It is up to participants to determine whether the relationships influence the activity faculty with regard to exposition or conclusions. If at any time during this activity you feel that there has been commercial/promotional bias, notify the Activity Director or Activity Coordinator. Please answer the questions about balance and objectivity in the activity evaluation candidly.

All of the relevant financial relationships listed for these individuals have been mitigated.